- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04867031
Impact of the Food Matrix on Iodine Bioavailability
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Iodine insufficiency is one of the three key micronutrient deficiencies highlighted as major public health issues by the World Health Organisation, and recent evidence indicates that the UK is now iodine deficient. Iodine deficiency represents a particular threat for women of child-bearing age, unborn infants and young children, as iodine is essential to synthesise the thyroid hormones, which are involved in key metabolic function including fetal brain development. Maternal iodine deficiency and the resulting changes in thyroid function has been associated with adverse pregnancy outcomes including spontaneous miscarriage, fetal distress and death, preterm delivery, low birth weight and impaired neuropsychological development, with significant impact on later life development and quality of life.
There is no iodine fortification programme in the United Kingdom, and despite worldwide efforts to tackle iodine deficiency and associated disorders via iodine supplementation and food-fortification (of salt mainly), consumption of supplements in the UK is virtually non-existent, with iodised salt used by less than 5%.
In the UK, the main dietary sources of iodine are dairy and sea-foods. Our previous studies have shown that seaweed intake can increase the iodine status of women with diets habitually low in iodine. Reduced bioavailability of iodine from the seaweed matrix, which could have implications for dietary recommendations.
This study address the influence of the food matrix on iodine bioavailability, in the context of food guidelines and assessment of the iodine status.
This project is in collaboration with the British Broadcast Corporation (BBC).
The study design is a crossover randomised trial - to last 9 days, plus three days pre-trial washout [total 12 days] - with 3 arms:
- fish arm: portion equivalent to 140 µg iodine, approx. 130g.
- milk arm: portion equivalent to 140 µg iodine, approx. 450mL.
- seaweed arm: portion equivalent to 140 µg iodine, approx. 6g.
Each arm will be separated by two washout days, and participants will follow a low iodine diet (avoiding dairy, and all seafood) throughout the study, as well as three days prior to the first arm. Iodine levels will be monitored in urine collected during the 12 hours preceding and 36 hours following the meal. Urine will be collected in time fractions
A parallel design study showed that 56% (SD 20%) of a dose of potassium iodide is excreted after 24hours, compared to 36% (SD 13%) when the same dose comes from seaweed. In order to detect a similar difference, a sample of at least 13 participants is required (n=19 to allow for 30% attrition).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Lanarkshire
-
Glasgow, North Lanarkshire, United Kingdom, G31 2ER
- Section of Human Nutrition, University of Glasgow
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy
- Male or female
- Aged 18-48
- Signed informed consent
Exclusion Criteria:
- Pregnancy and lactation
- Past and present thyroid conditions
- Diseases of the gastrointestinal tract
- Allergy to seafood or dairy
- Consumption of iodine supplements
- Currently taking medication (other than the contraceptive pill)
- Having a habitual diet very low in iodine (<1 portion of dairy per day, or < 1 portion of fish per week)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: White fish (cod)
Participants will consume 1 portion (~130g) of white fish (Bird's Eye Inspirations Cod Fillets with Tomato & Rosemary), providing approximately 140µg of iodine, alongside 452mL of water.
Urine will be collected for 36 hours following test food consumption.
|
One portion of cod (approx.
130g), providing ~140µg of iodine.
|
|
Experimental: Semi-skimmed milk
Participants will consume 1 portion (~450mL) of milk (Tesco UHT Semi-Skimmed), providing approximately 140µg of iodine, alongside 452mL of water.
Urine will be collected for 36 hours following test food consumption.
|
One portion of semi-skimmed cow's milk (approx.
450mL), providing ~140µg of iodine.
|
|
Experimental: Dried seaweed sheets
Participants will consume 1 portion (~6g) of dried seaweed sheets (Itsu Crispy Seaweed Thins), providing approximately 140µg of iodine, alongside 452mL of water.
Urine will be collected for 36 hours following test food consumption.
|
One portion of dried seaweed sheets (approx.
6g), providing ~140µg of iodine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Iodine concentration in urine (µg/L)
Time Frame: 36 hours (fractions: 1-2, 2-3, 3-5, 5-7, 7-12, 12-24, 24-36 hours)
|
Measured using the Sandell-Kolthoff method
|
36 hours (fractions: 1-2, 2-3, 3-5, 5-7, 7-12, 12-24, 24-36 hours)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 200160161
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iodine Bioavailability
-
University of GlasgowNot yet recruitingIodine Bioavailability
-
Liu Xiao BingChangzhi Medical College; Shenzhen Center for Chronic Disease ControlEnrolling by invitationIodine BioavailabilityChina
-
Isabelle Herter-AeberliCompleted
-
DTU National Food InstituteUniversity Hospital Bispebjerg and FrederiksbergRecruitingDiet Habit | Iodine Deficiency | Iodine ToxicityDenmark
-
Universidade do PortoHospital de Braga; NOVA Medical School; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsCompletedIodine Deficiency | Iodine Status in PregnancyPortugal
-
Mahidol UniversityCompleted
-
University of GlasgowCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyUniversity of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's... and other collaboratorsCompletedIodine DeficiencyPhilippines, Switzerland, China, Croatia
-
qingya tangCompletedPregnancy | Iodine DeficiencyChina
Clinical Trials on Fish
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | OverweightNorway
-
University of Texas Southwestern Medical CenterUniversity of Massachusetts, WorcesterCompleted
-
University of CopenhagenAnjo A/SCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | Growth | Blood Pressure
-
Assiut UniversitySouth Egypt Cancer InstituteCompletedAcute Myeloid LeukemiaEgypt
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | Metabolic DisordersNorway
-
University of CopenhagenCompletedQuality of Life | Cancer Cachexia | Side EffectsDenmark
-
May Faraj, PDt, PhDDiabetes CanadaNot yet recruitingType 2 Diabetes | Obesity & Overweight | Prediabetes / Type 2 Diabetes | Obesity and Diabetes Mellitus, Type 2 | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Canada
-
National Institute of Respiratory Diseases, MexicoRecruitingLung Cancer | SurgeryMexico
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingMultiple Myeloma | Peripheral Neuropathy Due to Chemotherapy
-
Göteborg UniversityNot yet recruiting